$CTM

Merriman Andrew purchased $747 of CTM

Merriman Andrew (Chief Operating Officer) purchased 1,396 shares of Castellum, Inc. (CTM) at $0.54 on 2026-10-01.

Original reporting
SEC EDGAR · Merriman Andrew
Published Oct 1, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 8:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CTM
Neutral
high confidence
Mentioned
$CTM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTMNeutralLow
01

Why it matters

The filing provides a primary source of insider activity, but the modest size limits market impact.

02

Market read

Primary insider filing with limited trading relevance; may be noted by analysts but unlikely to drive price moves.

03

What to watch

Potential upcoming corporate actions or financing that prompted the insider purchase.

Relevance 4/10Novelty 4/10Timing: post‑market today

Background

SEC Form 4 filing discloses an insider transaction by Castellum's COO.

Company-level read

Ticker impact

$CTMNeutralHigh confidence
Context

COO Merriman Andrew purchased 1,396 shares of Castellum at $0.5352 per share, filing a Form 4 on 2026-10-01.

Expected impact

slight upward pressure as market absorbs insider buying

Evidence & confidence

The transaction is modest in size ($747) and unlikely to move the price significantly, but insider buying is generally viewed positively.

Market effects

Minimal impact on the REIT sector; insider activity may be noted by analysts.

US equity market

low

Counterpoint

The purchase is too small to signal confidence; investors may ignore it.

Key entities

  • Castellum, Inc.

    US‑listed REIT (ticker CTM) whose COO made the purchase.

  • Merriman Andrew

    Chief Operating Officer of Castellum who bought shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTMMed

Castellum Q2 Earnings Call Highlights

Castellum reported Q2 backlog of $271.7M and a qualified pipeline of $953.5M. CFO David Bell said at least 16% of June 30 backlog is expected to be recognized over 12 months and about 48% over 36 months, noting government funding timing. The CTM venture won a Navy Logistics IT Integration contract (max ~$250M). Gross profit fell to $4.7M (34% of revenue). Net loss was $1.0M.

$CTMMed

Canterra Minerals Commences Phase 2 Drill Program to Advance District-Scale Copper-Zinc Growth Strategy at Buchans, Newfoundland

Canterra Minerals (TSXV: CTM, OTCQB: CTMCF, FSE: DXZB) started an ~8,000 m Phase 2 diamond drill program at its Buchans copper-zinc district in Newfoundland, including ~2,000 m at the Lundberg deposit. The company aims to support a maiden Lundberg mineral resource estimate targeted for Q4 2026 and test satellite targets. It also reported ~$1.13M from warrant and option exercises.

$CTMMedAI 8/10

CTM uncovers Australian revenue errors dating back to 2019, delays financial statements

Corporate Travel Management (CTM) said in an ASX update that it has delayed lodgement of its overdue FY25 and first-half FY26 financial statements to August 2026. The audit found new issues: CTM expects to restate ANZ FY24 revenue by $10–15m, mainly from FY19–FY23 rebate accounting, and identified UK air booking margin contracts needing further review. CTM also disclosed goodwill impairments (GBP 92m Europe, AUD 77m ANZ, USD 49m North America) and ongoing lender discussions tied to a UK £118m ov